Table 5.
Methylation levels of specific sites between RA patients and controls.
Group | RA patients (n = 122) | Controls (n = 123) | P value |
---|---|---|---|
CYP2R1_1 | 0.0072 (0.0068,0.0076) | 0.0072 (0.0065,0.0077) | 0.708 |
CYP2R1_2 | 0.0071 (0.0066,0.0079) | 0.0072 (0.0065,0.0079) | 0.960 |
CYP24A1_1 | 0.0136 (0.0120,0.0155) | 0.0143 (0.0127,0.0164) | 0.032 |
CYP24A1_2 | 0.0615 (0.0560,0.0700) | 0.0640 (0.0554,0.0737) | 0.228 |
CYP24A1_3 | 0.0314 (0.0267,0.0376) | 0.0318 (0.0271,0.0384) | 0.607 |
CYP24A1_4 | 0.0662 (0.0577,0.0774) | 0.0685 (0.0613,0.0791) | 0.206 |
VDR_1 | 0.0316 (0.0260,0.0378) | 0.0357 (0.0311,0.0421) | <0.001 |
VDR_2 | 0.0121 (0.0114.0.0129) | 0.0121 (0.0108,0.0130) | 0.516 |
CYP27B1_1 | 0.0307 (0.0263,0.0373) | 0.0345 (0.0308,0.0412) | <0.001 |
Bold value means P < 0.05.